SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

9 Oct 2014 07:00

RNS Number : 8130T
Victrex PLC
09 October 2014
 



 

 

 

 

9 October 2014

 

Victrex plc - Pre-close trading statement

 

"A strong finish to 2014 - growth momentum continues"

 

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its pre-close trading statement for the financial year ended 30 September 2014, ahead of its preliminary results on Tuesday 9 December 2014.

 

Victrex delivered a strong finish to 2014, with the Group continuing its volume growth momentum from the first half year across our strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Full year Group sales volume of 3,551 tonnes increased by 22% (2013: 2,920 tonnes), with second half year sales volume of 1,967 tonnes increasing by 29% on last year (H2 2013: 1,528 tonnes). Although sales volumes were particularly strong, our profit expectations remain largely unchanged.

 

The strong volume performance in our Victrex Polymer Solutions (VPS) business reflects core growth and higher than expected volumes in the second half year from Consumer Electronics. Stripping out sales volumes across the entire Electronics segment, second half year sales volume increased by 6% on the prior year. Our higher margin Speciality Products business, including Aptiv film, again performed well during the year. With continued growth in Aptiv, we will bring an additional production line on stream during the first half of our new financial year.

 

In our higher margin Invibio medical business, full year revenue increased by 5% to £53.4m (2013: £50.8m), reflecting steady improvement in the Spine market. The focus for 2015 remains the roll-out of new products into the Spine market, with regulatory applications lodged in the US and Europe for the innovative PEEK-OPTIMA® HA-Enhanced product, which enhances bone-on-growth. Pending regulatory approval, adoption and roll-out will commence during the first half.

 

As we start our new financial year, our growth momentum remains positive. Although currency headwinds remain considerable in 2015, our forthcoming new PEEK and Aptiv film capacity, technical excellence and marketing know-how keep us well placed to continue driving growth and creating value, in line with our long term strategy.

 

Enquiries:

 

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead / Rebecca Hall +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions focused on the strategic markets of Aerospace, Automotive, Electronics, Energy and Medical. Every day, millions of people rely on products or applications which contain our polymers, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Visit www.victrexplc.com

 

Investor and analyst call:

A call for investors and analysts will be held today, Thursday 9 October 08.30 UK time. For dial in details contact Rebecca Hall at Pendomer on +44 (0) 203 603 5220 or Rebecca.Hall@pendomer.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGBAUUPCGCR
Date   Source Headline
18th Jun 20092:57 pmRNSDirector/PDMR Shareholding
18th Jun 20092:37 pmRNSDirector/PDMR Shareholding
3rd Jun 200911:29 amRNSBlocklisting Interim Review
2nd Jun 20093:51 pmRNSHolding(s) in Company
29th May 20091:30 pmRNSTotal Voting Rights
19th May 20094:02 pmRNSDirector/PDMR Shareholding
19th May 20097:00 amRNSHalf Yearly Report
30th Apr 200912:03 pmRNSTotal Voting Rights
17th Apr 20093:13 pmRNSDirector/PDMR Shareholding
15th Apr 200912:05 pmRNSHolding(s) in Company
7th Apr 20097:00 amRNSHalf Year Trading Update
31st Mar 20091:48 pmRNSTotal Voting Rights
30th Mar 200910:46 amRNSHolding(s) in Company
18th Mar 200911:54 amRNSDirector/PDMR Shareholding
4th Mar 20092:18 pmRNSDirector/PDMR Shareholding
2nd Mar 20092:41 pmRNSTotal Voting Rights
18th Feb 20093:41 pmRNSDirector/PDMR Shareholding
17th Feb 20094:45 pmRNSDirector/PDMR Shareholding
11th Feb 200910:41 amRNSResult of AGM
10th Feb 20097:00 amRNSAGM and Interim Management Statement
19th Jan 20092:35 pmRNSDirector/PDMR Shareholding
7th Jan 200911:11 amRNSAnnual Information Update
5th Jan 20093:13 pmRNSAnnual Report and Accounts
5th Jan 20092:07 pmRNSTotal Voting Rights
18th Dec 200812:21 pmRNSDirector/PDMR Shareholding
18th Dec 200810:53 amRNSDirector/PDMR Shareholding
16th Dec 20087:00 amRNSFinal Results
2nd Dec 200810:52 amRNSBlocklisting Interim Review
1st Dec 20083:58 pmRNSHolding(s) in Company
1st Dec 20087:00 amRNSTrading Statement
28th Nov 20082:32 pmRNSTotal Voting Rights
24th Nov 200811:40 amRNSDirector/PDMR Shareholding
21st Nov 20082:47 pmRNSHolding(s) in Company
20th Nov 20084:36 pmRNSHolding(s) in Company
7th Nov 20089:49 amRNSTotal Voting Rights
21st Oct 200812:01 pmRNSDirector/PDMR Shareholding
7th Oct 20087:00 amRNSAnnual Trading Update
30th Sep 20082:57 pmRNSTotal Voting Rights
18th Sep 20083:31 pmRNSDirector/PDMR Shareholding
29th Aug 20081:40 pmRNSTotal Voting Rights
20th Aug 200811:30 amRNSDirector/PDMR Shareholding
31st Jul 20084:15 pmRNSTotal Voting Rights
31st Jul 20087:00 amRNSInterim Management Statement
28th Jul 200812:54 pmRNSBoard Appointments
17th Jul 20083:34 pmRNSDirector/PDMR Shareholding
1st Jul 200810:15 amRNSTotal Voting Rights
20th Jun 20082:27 pmRNSHolding(s) in Company
19th Jun 20082:33 pmRNSDirector/PDMR Shareholding
13th Jun 20081:06 pmRNSDirector/PDMR Shareholding
30th May 200811:01 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.